Discontinued — last reported Q1 '20

Products & Services · Finite Lived Intangible Assets Net

Tysabri Product — Finite Lived Intangible Assets Net

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ2 2018
Last reportedQ1 2020

How to read this metric

A decrease typically indicates ongoing amortization or potential impairment charges, while an increase suggests new capitalizable investments or acquisitions related to the product line. Significant declines may signal a shortening of the product's remaining commercial life or competitive obsolescence.

Detailed definition

This metric represents the carrying value of the Tysabri product-related intangible assets, net of accumulated amortizat...

Peer comparison

Comparable to capitalized product rights or acquired intangible assets reported by other biopharmaceutical companies for specific drug franchises.

Metric ID: biib_segment_tysabri_product_finite_lived_intangible_assets_net

Frequently Asked Questions

What does tysabri product — finite lived intangible assets net mean?
The net book value of the Tysabri product's intellectual property and related intangible assets after accounting for amortization.